Maria Liberti

Maria Liberti awarded National Cancer Institute F99/K00 Fellowship

Maria Liberti (2013) was awarded a Predoctoral to Postdoctoral Fellowship from the NCI entitled “Metabolic and Genetic Heterogeneity in Cancer”. Her PhD work has focused on therapeutic targeting of enzymes that differentially regulate the Warburg Effect – a form of glucose metabolism commonly observed in cancers – and determining the anti-tumor efficacy. Thus far, her studies have shown that the current understanding of cancer therapy likely requires knowledge encoded at the metabolic level to predict therapeutic response. Current work focuses on characterizing resistance mechanisms to glycolysis inhibition to develop combination therapies and better understand the requirements of the Warburg Effect. For her postdoctoral work, she plans to study differences in tumor microenvironment settings to unravel the molecular components contributing to tumor heterogeneity.